Product Overview

Amaryl 2mg is a prescription oral antidiabetic tablet manufactured by Sanofi India Limited. It belongs to the sulfonylurea class of drugs and is specifically indicated for the management of Type 2 diabetes mellitus. Each strip contains 30 tablets, providing a convenient supply for patients requiring consistent glycemic control. The product is marketed in strengths of 2mg, 60 Tablet/s, 90 Tablet/s, with pack sizes available to suit individual treatment regimens. Proper storage at room temperature and protection from moisture are recommended to maintain tablet integrity.

What is Amaryl 2mg (Glimepiride)

Glimepiride, the active ingredient in Amaryl, is a potent oral hypoglycemic agent that stimulates pancreatic beta‑cells to increase insulin secretion. As a second‑generation sulfonylurea, it offers a favorable pharmacokinetic profile with once‑daily dosing. The medication is classified under the therapeutic category of Diabetes Care and is listed in major drug databases such as Drugs.com and the FDA’s National Drug Code directory. Its bioavailability is high, and it is primarily metabolized by the liver via the cytochrome P450 system.

Uses and Benefits

The primary use of Amaryl 2mg is to lower blood glucose levels in adults with Type 2 diabetes who have not achieved adequate control through diet and exercise alone. Clinical studies demonstrate that regular use can reduce HbA1c by approximately 0.5% to 1.0% over 12 weeks, contributing to a decreased risk of microvascular complications. Additional benefits include improved pancreatic beta‑cell function and potential weight neutrality when combined with lifestyle modifications. Patients often experience sustained glycemic stability, which supports long‑term disease management.

How It Works

Amaryl exerts its antidiabetic effect by binding to the Kir6.2 subunit of the ATP‑sensitive potassium channel on pancreatic beta‑cells. This binding leads to closure of the channel, depolarization of the cell membrane, and subsequent influx of calcium ions, triggering insulin release. The newly secreted insulin enhances peripheral glucose uptake and suppresses hepatic glucose production, thereby reducing circulating glucose concentrations. The drug’s onset of action typically occurs within 1–2 hours after oral administration, with peak effects observed around 2–3 hours post‑dose.

Dosage Guidelines

Initial therapy usually starts with a single 2mg tablet taken before breakfast or the first main meal of the day. Dosage may be titrated upward in increments of 1–2mg based on glycemic response, with a typical maximum daily dose of 8mg divided into two doses. Adjustments are recommended for patients with renal impairment or hepatic dysfunction, as well as for elderly individuals at increased risk of hypoglycemia. It is essential to monitor blood glucose regularly and to adjust the dose only under medical supervision. Missed doses should be taken as soon as remembered unless it is near the time of the next scheduled dose; duplicate dosing should be avoided.

Side Effects

Like all medications, Amaryl 2mg may cause adverse effects. The most commonly reported side effects include hypoglycemia, dizziness, headache, and mild gastrointestinal discomfort. Less frequent but clinically significant events comprise skin rash, pruritus, and rare cases of hepatic enzyme elevation. Patients should be instructed to recognize early signs of low blood sugar, such as sweating, tremors, and confusion, and to treat episodes promptly with carbohydrate intake. Laboratory monitoring of liver function tests is advisable during prolonged therapy.

Warnings and Precautions

Amaryl is contraindicated in patients with Type 1 diabetes, diabetic ketoacidosis, or a history of hypersensitivity to glimepiride or any component of the formulation. Caution is advised in individuals with severe renal or hepatic disease, adrenal or pituitary insufficiency, or those undergoing surgery. Concomitant use with certain medications, such as certain beta‑blockers or non‑steroidal anti‑inflammatory drugs, may potentiate hypoglycemia. Pregnant and lactating women should avoid this medication unless explicitly prescribed by a healthcare professional. Always consult a physician before initiating or modifying therapy.

Frequently Asked Questions

1. Can Amaryl 2mg be taken with food? Yes, the tablet should be taken with the first main meal of the day to maximize absorption and reduce the risk of gastrointestinal upset.
2. How long does it take to see a reduction in blood sugar levels? Most patients observe a measurable decrease in fasting glucose within 1–2 weeks of consistent use, with maximal glycemic effect achieved after 4–6 weeks.
3. Is Amaryl safe for patients with kidney disease? Dosage adjustments are recommended for moderate to severe renal impairment; patients should consult their physician before use.
4. What should I do if I miss a dose? Take the missed dose as soon as you remember, but if it is almost time for the next scheduled dose, skip the missed dose and resume your regular schedule.
5. Can Amaryl cause weight gain? Unlike some other antidiabetic agents, glimepiride is generally weight‑neutral; however, individual responses may vary.

For additional scientific insight, refer to the National Institutes of Health overview of sulfonylurea antidiabetic agents and the U.S. Food and Drug Administration prescribing information.

Related Products

• Allegra (Fexofenadine)
• Fexofenadine 30 Mg (Generic)
• Fexofenadine 120 Mg (Generic)
• Fexofenadine 180 Mg (Generic)
• Allegra 120 mg (Fexofenadine)
• Allegra 30mg (Fexofenadine)
• Allegra Nasal Duo Spray (Fluticasone / Azelastine)
• Allegra 180 mg (Fexofenadine)
• Okamet 500 Mg (Metformin)
• Framycetin Sulphate Cream (Generic)
• Teicoplanin 400mg (Generic)
• Soframycin Cream (Framycetin Sulphate)